BIVALIRUDIN (BIVALIRUDIN) — FDA Approval ANDA202471 (MYLAN INSTITUTIONAL)
BIVALIRUDIN (BIVALIRUDIN) — FDA Approval ANDA202471 (MYLAN INSTITUTIONAL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BIVALIRUDIN; Active ingredients: BIVALIRUDIN; Application number: ANDA202471.
| Brand name | BIVALIRUDIN |
|---|---|
| Active ingredients | BIVALIRUDIN |
| Application number | ANDA202471 |
| Sponsor | MYLAN INSTITUTIONAL |
| Dosage form | INJECTABLE |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20180601 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →